Tuesday, November 28, 2023
11:00AM – 12:00PM ET
Please note this TeleECHO program is 11:00AM Eastern, 10:00AM Central, 9:00AM Mountain and 8:00AM Pacific.
|Anju T. Peters, MD MSCI
Professor of Medicine
Director of Clinical Research
Division of Allergy and Immunology
Director, Center for Clinical Research
Northwestern University Clinical and Translational Sciences Institute (NUCATS)
Northwestern University Feinberg School of Medicine
This teleECHO series will help healthcare professionals identify evidence-based strategies to manage chronic rhinosinusitis with nasal polyps (CRSwNP), understand the clinical evidence for novel, emerging therapies for CRSwNP, and choose the most appropriate treatment based on individual patient characteristics.
This activity is designed to meet the educational needs of otolaryngologists, allergists, primary care physicians, nurses, nurse practitioners, pharmacists, and other members of the multidisciplinary team that care for patients with CRSwNP.
Upon the completion of this program, attendees should be able to:
- Identify strategies to manage CRSwNP that are aligned with evidence-based guidelines
- Discuss the clinical evidence for novel, emerging therapeutic agents for the treatment of CRSwNP
- Describe strategies to effectively select treatment based on patient-specific factors and expert guidance
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the (ACCME) Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]